Related references
Note: Only part of the references are listed.Delivery of Immunostimulatory RNA Oligonucleotides by Gelatin Nanoparticles Triggers an Efficient Antitumoral Response
Carole Bourquin et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Joerg Vollmer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer
Kai Xiao et al.
BIOMATERIALS (2009)
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial
G. Senti et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Mixed Inheritance of Equine Recurrent Airway Obstruction
V. Gerber et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2009)
A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma
Qinghua Zhou et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2009)
Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics
Andrew G. Jarnicki et al.
JOURNAL OF IMMUNOLOGY (2008)
Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity
Carole Bourquin et al.
JOURNAL OF IMMUNOLOGY (2008)
Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides
Klaus Zwiorek et al.
PHARMACEUTICAL RESEARCH (2008)
Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma
Dominik Hartl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation
Marion Jurk et al.
BIODRUGS (2007)
Immunotherapy of asthma using CpG oligodeoxynucleotides
Joel N. Kline
IMMUNOLOGIC RESEARCH (2007)
Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death
Przemyslaw Lewkowicz et al.
JOURNAL OF IMMUNOLOGY (2006)
The regulation of allergy and asthma
Dale T. Umetsu et al.
IMMUNOLOGICAL REVIEWS (2006)
Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β:: the role of T regulatory cells
A Taylor et al.
IMMUNOLOGY (2006)
Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism
C Montagnoli et al.
JOURNAL OF IMMUNOLOGY (2006)
Endoscopic scoring of mucus quantity and quality: observer and horse variance and relationship to inflammation, mucus viscoelasticity and volume
V Gerber et al.
EQUINE VETERINARY JOURNAL (2004)
Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity
P Stock et al.
NATURE IMMUNOLOGY (2004)
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells
EA Moseman et al.
JOURNAL OF IMMUNOLOGY (2004)
Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide
I Caramalho et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
CpG motifs as possible adjuvants for the treatment of allergic diseases
B Bohle
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile
JP Lavoie et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Share Paper
